Patients with type 2 diabetes and obstructive sleep apnea who used continuous positive airway pressure (CPAP) saw improved glycemic control during the night.

Psoriasis and metabolic syndrome both are associated with high serum levels of leptin, according to a new report. “Body weight loss could potentially become part of the general treatment of psoriasis, especially in patients with obesity.”

Therapy with alogliptin alone is significantly reduced glycosylated hemoglobin A1c levels in patients with type 2 diabetes and inadequate glycemic control, according to a double-blind, placebo-controlled, multicenter trial reported this month.

A once-daily, fixed-dose tablet combining atorvastatin and a novel micronized formulation of fenofibrate outperformed either drug alone in a phase II clinical trial in patients with mixed dyslipidemia.

Blood levels of two insulin-related proteins are able to predict which patients with colon cancer are most likely to die of their disease by 87%, new research suggests.

Phase 1 clinical trial of APD597, a novel first in class oral drug candidate that targets the glucose-dependent insulinotropic receptor (GDIR) for the treatment of type 2 diabetes will begin shortly. The GDIR has the potential to stimulate insulin release in response to increases in blood glucose. Ortho-McNeil-Janssen Pharmaceuticals will be …

The success of weight-loss in overweight and obese individuals with type 2 diabetes is not affected by a history of binge eating, according to a report in the Archives of General Psychiatry.

Adding to earlier research, a new study has identified a genetic variation that increases the risk of coronary artery disease (CAD) in type 2 diabetes patients with poor sugar glucose (glycemic) control.

In people with type 2 diabetes, intensive drug therapy to significantly lower “bad” LDL cholesterol reduces the thickness of the carotid arteries, the major arteries in the neck that supply oxygen to the brain, research shows.

A group of researchers conducted a study to investigate the role of blood glucose (BG) variability in glycemic control in patients with type 2 diabetes.